Industry News
Pharmaceutical Industry News
Moderna, after monumental commercial debut, forecasts $22B in COVID shot sales this year
Moderna, after monumental commercial debut, forecasts $22B in COVID shot sales this year fkansteiner Thu, 02/24/2022 - 08:43
Regeneron, Bayer’s Eylea ‘to remain king’ as analysts see ‘tepid’ response to biosimilar threats
Regeneron, Bayer's Eylea 'to remain king' as analysts see 'tepid' response to biosimilar threats badams Thu, 02/24/2022 - 08:30
Sanofi presses CDC experts to back its high-dose Fluzone shot for older adults
Sanofi presses CDC experts to back its high-dose Fluzone shot for older adults fkansteiner Thu, 02/24/2022 - 07:13
Alkermes’ Lybalvi launch serves as a new litmus test for mental illness marketing
Alkermes' Lybalvi launch serves as a new litmus test for mental illness marketing badams Thu, 02/24/2022 - 05:48
Lundbeck teams up with Mental Health America to tackle the other COVID crisis
Lundbeck teams up with Mental Health America to tackle the other COVID crisis badams Thu, 02/24/2022 - 04:39
Why Do I Wake Up With a Headache?
And is there anything I can do to find relief?
‘Major blunder:’ Ex-staffers blast Bristol Myers Squibb’s handling of Breyanzi approval in latest CVR lawsuit update
'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update fkansteiner Wed, 02/23/2022 - 11:57
Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe
Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe kdunleavy Wed, 02/23/2022 - 11:14
Gearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with $85M for key launch
Gearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with $85M for key launch aliu Wed, 02/23/2022 - 10:42
Intellia leases new facility to produce CRISPR-based therapies
Intellia leases new facility to produce CRISPR-based therapies jkeenan Wed, 02/23/2022 - 10:40
Johnson & Johnson, Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing
Johnson & Johnson, Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing esagonowsky Wed, 02/23/2022 - 10:27
UPDATED: J&J, Pfizer and Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing
UPDATED: J&J, Pfizer and Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing esagonowsky Wed, 02/23/2022 - 10:27
UPDATED: Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing
UPDATED: Pfizer to join J&J, Moderna in shareholder vote showdown on vaccine pricing strategy, manufacturing tech sharing esagonowsky Wed, 02/23/2022 - 10:27
Mallinckrodt blames manufacturing issue for FDA rejection of its rare kidney disorder med
Mallinckrodt blames manufacturing issue for FDA rejection of its rare kidney disorder med kdunleavy Wed, 02/23/2022 - 09:45
AbbVie advances major depressive disorder ambitions for Vraylar with hopes for $4B-plus in sales
AbbVie advances major depressive disorder ambitions for Vraylar with hopes for $4B-plus in sales fkansteiner Wed, 02/23/2022 - 09:30
Moderna taps Thermo Fisher for 15-year mRNA production pact for COVID vaccines and more
Moderna taps Thermo Fisher for 15-year mRNA production pact for COVID vaccines and more fkansteiner Wed, 02/23/2022 - 08:37
What do patients really think about their meds? A new AI bot can tell you
What do patients really think about their meds? A new AI bot can tell you sharon.coey Wed, 02/23/2022 - 07:51
Relevate Health, on a digital marketing buyout spree, snaps up Axon Communications
Relevate Health, on a digital marketing buyout spree, snaps up Axon Communications badams Wed, 02/23/2022 - 05:15
Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODT
Biohaven lines up rhinosinusitis patients for trial of its migraine med Nurtec ODT kdunleavy Tue, 02/22/2022 - 11:27
March-in campaign on Pfizer’s prostate cancer med Xtandi gets congressional backing. Will it matter?
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter? fkansteiner Tue, 02/22/2022 - 10:38